Limited proteolysis of human histone deacetylase 1

BMC Biochemistry

Volumn 7, Issue , 2006, Pages

  Kamath, Nayana ^a   Karwowska Desaulniers, Paulina ^a   Pflum, Mary Kay H ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 1; TRYPSIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; GENE EXPRESSION; HISTONE DEACETYLASE 1; HISTONE DEACETYLASES; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; TRYPSIN;

EID: 33750082661     PISSN: 14712091     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-7-22     Document Type: Article

References (45)

1. Grunstein M: Histone acetylation in chromatin structure and transcription. Nature 1997, 389:349-352.
2. Ruijter AJM, Gennip AH, Caron HN, Kemp S, Kuilenburg ABP: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370:737-749.
3. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG: Fusion proteins of the retinoic acid receptor-a recruit histone deacetylase in promyelocytic leukaemia. Nature 1998, 391:815-818.
4. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH, Evans RM: Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998, 391:811-814.
5. Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK: Histone Deacetylases and Cancer: Causes and Therapies. Nature Reviews Cancer 2001, 1(3):194.
6. Dokmanovic M, Marks PA: Prospects: Histone deacetylase inhibitors. J Cell Biochem 2005, 96(2):293-304.
7. Wang DF, Helquist P, Wiech NL, Wiest O: Toward Selective Histone Deacetylase Inhibitor Design: Homology Modeling, Docking Studies, and Molecular Dynamics Simulations of Human Class I Histone Deacetylases. J Med Chem 2005, 48(22):6936-6947.
8. Kelly WK, O'Connor OA, Krug LM, Chiao JH, Heaney M, Curley T, MacGregore-Cortelli B, Tong W, Secrist JP, Schwartz L, Richardson S, Chu E, Olgac S, Marks PA, Scher H, Richon VM: Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer. J Clin Oncol 2005, 23(17):3923-3931.
9. Ryan QC, Headlee D, Acharya M, Sparreboom A, Trepel JB, Ye J, Figg WD, Hwang K, Chung EJ, Murgo A, Melillo G, Elsayed Y, Monga M, Kalnitskiy M, Zwiebel J, Sausville EA: Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma. J Clin Oncol 2005, 23(17):3912-3922.
10. Gregoretti IV, Lee YM, Goodson HV: Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic Analysis. Journal of Molecular Biology 2004, 338(1):17.
11. Glaser KB, Li J, Staver MJ, Wei RQ, Albert DH, Davidsen SK: Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA. Biochem Biophys Res Comm 2003, 310:529-536.
12. Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C: Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 2002, 21(11):2672-2681.
13. Bartl S, Taplick J, Lagger G, Khier H, Kuchler K, Seiser C: Identification of mouse histone deacetylase 1 as a growth factorinducible gene. Mol Cell Biol 1997, 17(9):5033-5043.
14. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL: Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 1998, 395(6705):917-921.
15. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W: NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 1998, 2(6):851-861.
16. Zhang Y, Ng H, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D: Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999, 13:1924-1935.
17. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE: Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 1997, 89:341-347.
18. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D: Histone deactylase and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 1997, 89:357-364.
19. Zhang Y, Sun Z, Iratni R, Erdjument-Bromage H, Tempst P, Hampsey M, Reinberg D: SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol Cell 1998, 1:1021-1231.
20. Alland L, David G, Shen-Li H, Potes J, Muhle R, Lee HC, Hou HJ, Chen K, DePinho RA: Identification of Mammalian Sds3 as an Integral Component of the Sin3/Histone Deacetylase Corepressor Complex. Mol Cell Biol 2002, 22(8):2743-2750.
21. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN: Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression. Cell 1997, 89(3):349.
22. You A, Tong JK, Grozinger CM, Schreiber SL: CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc Natl Acad Sci USA 2001, 98(4):1454-1458.
23. Humphrey GW, Wang Y, Russanova VR, Hirai T, Qin J, Nakatani Y, Howard BH: Stable Histone Deacetylase Complexes Distinguished by the Presence of SANT Domain Proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem 2001, 276(9):6817-6824.
24. Pflum MKH, Tong JK, Lane WS, Schreiber SL: Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J Biol Chem 2001, 276(50):47733-47741.
25. Cai R, Kwon P, Yan-Neale Y, Sambuccetti L, Fischer D, Cohen D: Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation. Biochem Biophys Res Comm 2001, 283:445-453.
26. Galasinski SC, Resing KA, Goodrich JA, Ahn NG: Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions. J Biol Chem 2002, 277(22):19618-19626.
27. PeptideCutter. :[http://us.expasy.org/tools/peptidecutter/].
28. Vannini A, Volpari C, Filocamo G, Casavola EC, Brunetti M, Renzoni D, Chakravarty P, Paolini C, Francesco RD, Gallinari P, Steinkuhler C, Marco SD: Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc Natl Acad Sci U S A 2004, 101(42):15064-15069.
29. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Pavletich NP: Structure of a histone deacetylase homologue bound to trichostatin A. Nature 1999, 401:188-193.
30. Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, Jennings AJ, Luong C, Arvai A, Buggy JJ, Chi E, Tang J, Sang BC, Verner E, Wynands R, Leahy EM, Dougan DR, Snell G, Navre M, Knuth MW, Swanson RV, McRee DE, Tari LW: Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases. Structure 2004, 12:1324-1334.
31. Nielsena TK, Hildmannb C, Dickmannsa A, Schwienhorstb A, Ficner R: Crystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue. J Mol Biol 2005, 354(1):107-120.
32. Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL: A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A 1998, 95:3519-3524.
33. Li J, Staver MJ, Curtin ML, Holms JH, Frey RR, Edalji R, Smith R, Michaelides MR, Davidsen SK, Glaser KB: Expression and functional characterization of recombinant human HDAC1 and HDAC3. Life Sciences 2004, 74:2693-2705.
34. Fontana A, Polverino de Laureto P, De Filippis V, Scaramella E, Zambonin M: Probing the partly folded states of proteins by limited proteolysis. Folding and Design 1997, 2(2):R17.
35. Raboni S, Bettati S, Mozzarelli A: Identification of the Geometric Requirements for Allosteric Communication between the alpha- and beta- Subunits of Tryptophan Synthase. J Biol Chem 2005, 280(14):13450-13456.
36. Jiang ZG, Carraway M, McKnight CJ: Limited Proteolysis and Biophysical Characterization of the Lipovitellin Homology Region in Apolipoprotein B. Biochemistry 2005, 44:1163-1173.
37. Arnold U, Ulbrich-Hofmann R: Kinetic and Thermodynamic Thermal Stabilities of Ribonuclease A and Ribonuclease B. Biochemistry 1997, 36(8):2166-2172.
38. Pipal A, Goralik-Schramel M, Lusser A, Lanzanova C, Sarg B, Loidl A, Lindner H, Rossi V, Loidl P: Regulation and Processing of Maize Histone Deacetylase Hda1 by Limited Proteolysis. Plant Cell 2003, 15(8):1904-1917.
39. Schwer B, North BJ, Frye RA, Ott M, Verdin E: The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol 2002, 158(4):647-657.
40. Fleischer TC, Yun UJ, Ayer DE: Identification and Characterization of Three New Components of the mSin3A Corepressor Complex. Mol Cell Biol 2003, 23(10):3456-3467.
41. Zhang Y, LeRoy G, Seelig H, Lane WS, Reinberg D: The Dermatomyositis- Specific Autoantigen Mi2 is a Component of a Complex Containing Histone Deactylase and Nucleosome Remodeling Activities. Cell 1998, 95:279-289.
42. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T: Retinoblastoma Protein Recruits Histone Deacetylase to Repress Transcription. Nature 1998, 391:597-601.
43. Kawai H, Li H, Avraham S, Jiang S, Avraham HK: Overexpression of Histone Deacetylase HDAC1 Modulates Breast Cancer Progression by Negative Regulation of Estrogen Receptor Alpha. International Journal of Cancer 2003, 107(3):353-358.
44. Kang JE, Kim MH, Lee JA, Park H, Min-Nyung L, Auh CK, Hur MW: Histone Deacetylase-1 Represses Transcription by Interacting with Zinc-Fingers and Interfering with the DNA Binding Activity of Sp1. Cellular Physiology and Biochemistry 2005, 16(1-3):23.
45. Sengupta N, Seto E: Regulation of histone deacetylase activities. J of Cell Biochem 2004, 93(1):57-67.